Sponsor & Developer Portfolio
University of Sao Paulo General Hospital
Clinical development pipeline, platform architecture, and registered trial tracking for University of Sao Paulo General Hospital vaccine candidates.
2
Candidates
2
Target Diseases
3
Linked Studies
Development Phase Distribution
Phase 3 Clinical Trial: 2
Platform Technologies
Biological (unspecified platform): 1 Protein / subunit: 1
Target Pathogens & Indications
Autoimmune Rheumatologic Disease Varicella / Zoster
Vaccine Pipeline Candidates (2)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
Phase 3 Clinical Trial
ctgov-pneumococcal-vaccine-university-of-sao-paulo-general-hospital
Pneumococcal Vaccine
Target: Autoimmune Rheumatologic Disease
Platform: Biological (unspecified platform)
Key Milestone: Primary completion (most advanced trial): 2026-12-30 (registry estimate)
Phase 3 Clinical Trial
ctgov-recombinant-zoster-vaccine-rzv-university-of-sao-paulo-general-h
Recombinant Zoster Vaccine (RZV)
Target: Varicella / Zoster
Platform: Protein / subunit
Key Milestone: Primary completion (most advanced trial): 2027-07-30 (registry estimate)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.